Grais Linda
Insider CIK 1413306 · ICLR Director · OCRX President and CEO, Director · ZSAN Director · PRAH Director · CRVS Director · ABIO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ICLR ICON PLC | S Sale | 2026-08-11 | 2026-08-12 | 97 | $163.77 | $15.9K | 6,819 | SEC↗ |
| ICLR ICON PLC | S Sale | 2026-08-11 | 2026-08-12 | 67 | $165.51 | $11.1K | 6,162 | SEC↗ |
| ICLR ICON PLC | S Sale | 2026-08-11 | 2026-08-12 | 590 | $164.47 | $97.0K | 6,229 | SEC↗ |
| ICLR ICON PLC | S Sale | 2026-08-11 | 2026-08-12 | 87 | $162.72 | $14.2K | 6,916 | SEC↗ |
| ICLR ICON PLC | S Sale | 2026-08-11 | 2026-08-12 | 67 | $165.51 | $11.1K | 6,162 | SEC↗ |
| ICLR ICON PLC | S Sale | 2026-08-11 | 2026-08-12 | 590 | $164.47 | $97.0K | 6,229 | SEC↗ |
| ICLR ICON PLC | S Sale | 2026-08-11 | 2026-08-12 | 97 | $163.77 | $15.9K | 6,819 | SEC↗ |
| ICLR ICON PLC | S Sale | 2026-08-11 | 2026-08-12 | 87 | $162.72 | $14.2K | 6,916 | SEC↗ |
| ICLR ICON PLC | A Award deriv | 2026-08-10 | 2026-08-12 | 1,324 | — | $0 | 1,324 | SEC↗ |
| ICLR ICON PLC | M Exercise deriv | 2026-08-10 | 2026-08-12 | 1,732 | — | $0 | 0 | SEC↗ |
| ICLR ICON PLC | M Exercise | 2026-08-10 | 2026-08-12 | 1,732 | — | $0 | 7,003 | SEC↗ |
| ICLR ICON PLC | A Award deriv | 2026-08-10 | 2026-08-12 | 1,324 | — | $0 | 1,324 | SEC↗ |
| ICLR ICON PLC | M Exercise deriv | 2026-08-10 | 2026-08-12 | 1,732 | — | $0 | 0 | SEC↗ |
| ICLR ICON PLC | M Exercise | 2026-08-10 | 2026-08-12 | 1,732 | — | — | 7,003 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2026-06-11 | 2026-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2025-06-12 | 2025-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2024-06-13 | 2024-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award deriv | 2024-01-30 | 2024-01-31 | 6,000 | — | $0 | 6,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2023-12-06 | 2023-12-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2023-06-15 | 2023-06-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2023-05-15 | 2023-05-16 | 10,000 | $2.45 | $24.5K | 10,000 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award deriv | 2022-12-15 | 2022-12-19 | 6,000 | — | $0 | 6,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2022-08-11 | 2022-08-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2022-06-15 | 2022-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2021-09-09 | 2021-09-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PRAH PRA Health Sciences, Inc. | D To issuer | 2021-07-01 | 2021-07-01 | 9,683 | — | $0 | 0 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2021-06-15 | 2021-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ZSAN Zosano Pharma Corp | A Award deriv | 2021-06-10 | 2021-06-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ZSAN Zosano Pharma Corp | A Award | 2021-06-10 | 2021-06-14 | 15,000 | — | $0 | 22,500 | SEC↗ |
| PRAH PRA Health Sciences, Inc. | A Award | 2021-06-01 | 2021-06-03 | 250 | — | $0 | 9,683 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award deriv | 2021-01-12 | 2021-01-13 | 12,000 | — | $0 | 12,000 | SEC↗ |
| ZSAN Zosano Pharma Corp | A Award | 2020-06-25 | 2020-06-29 | 7,500 | — | $0 | 7,500 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2020-06-09 | 2020-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ZSAN Zosano Pharma Corp | A Award deriv | 2020-06-03 | 2020-06-05 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ZSAN Zosano Pharma Corp | A Award deriv | 2020-06-03 | 2020-06-05 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PRAH PRA Health Sciences, Inc. | A Award | 2020-05-18 | 2020-05-20 | 1,324 | — | $0 | 9,433 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2020-03-19 | 2020-03-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2019-06-20 | 2019-06-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PRAH PRA Health Sciences, Inc. | A Award | 2019-06-03 | 2019-06-05 | 1,436 | — | $0 | 8,109 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2019-01-28 | 2019-01-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ZSAN Zosano Pharma Corp | A Award deriv | 2019-01-14 | 2019-01-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PRAH PRA Health Sciences, Inc. | A Award | 2018-06-21 | 2018-06-25 | 1,307 | — | $0 | 6,673 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award deriv | 2018-03-01 | 2018-03-05 | 8,000 | — | $0 | 8,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-11 | 30,827 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-11 | 11,969 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-11 | 30,826 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-11 | 37,500 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-11 | 491,550 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-11 | 160,000 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-11 | 348,600 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-11 | 289,200 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer | 2017-12-11 | 2017-12-11 | 70,000 | $1.52 | $106.4K | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer | 2017-12-11 | 2017-12-11 | 230,000 | $1.52 | $349.6K | 0 | SEC↗ |
| PRAH PRA Health Sciences, Inc. | A Award | 2017-07-12 | 2017-07-14 | 1,318 | — | $0 | 5,366 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award | 2017-03-29 | 2017-03-30 | 230,000 | — | $0 | 300,000 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award deriv | 2017-02-16 | 2017-02-21 | 8,000 | — | $0 | 8,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2016-12-15 | 2016-12-16 | 289,200 | — | $0 | 289,200 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | P Buy | 2016-12-07 | 2016-12-08 | 7,000 | $2.14 | $15.0K | 70,000 | SEC↗ |
| PRAH PRA Health Sciences, Inc. | A Award | 2016-06-17 | 2016-06-20 | 1,466 | — | $0 | 4,048 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | P Buy | 2016-03-04 | 2016-03-07 | 3,000 | $3.19 | $9.6K | 63,000 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award deriv | 2016-02-11 | 2016-02-16 | 8,000 | — | $0 | 8,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | P Buy | 2016-01-22 | 2016-01-25 | 10,000 | $2.38 | $23.8K | 60,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | P Buy | 2016-01-15 | 2016-01-19 | 10,000 | $2.08 | $20.8K | 50,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2016-01-06 | 2016-01-07 | 116,200 | — | $0 | 116,200 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2016-01-06 | 2016-01-07 | 348,600 | — | $0 | 348,600 | SEC↗ |
| PRAH PRA Health Sciences, Inc. | A Award | 2015-10-12 | 2015-10-13 | 2,582 | — | $0 | 2,582 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2015-06-18 | 2015-06-22 | 160,000 | — | $0 | 160,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | P Buy | 2015-05-06 | 2015-05-06 | 30,000 | $3.73 | $111.9K | 40,000 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award deriv | 2015-02-12 | 2015-02-17 | 8,000 | — | $0 | 8,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | P Buy | 2014-07-11 | 2014-07-15 | 10,000 | $5.93 | $59.3K | 10,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2014-06-11 | 2014-06-13 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award deriv | 2014-02-11 | 2014-02-13 | 8,000 | — | $0 | 8,000 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award deriv | 2013-09-17 | 2013-09-19 | 7,417 | — | $0 | 7,417 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award deriv | 2013-09-17 | 2013-09-19 | 16,000 | — | $0 | 16,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2013-08-13 | 2013-12-23 | 491,550 | — | $0 | 491,550 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award deriv | 2013-07-26 | 2013-07-30 | 583 | — | $0 | 583 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2013-07-15 | 2013-07-17 | 11,969 | — | $0 | 11,969 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2013-07-15 | 2013-07-17 | 61,653 | — | $0 | 61,653 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award deriv | 2012-02-10 | 2012-02-14 | 3,500 | — | $0 | 3,500 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award deriv | 2012-02-10 | 2012-02-14 | 3,500 | — | $0 | 3,500 | SEC↗ |